{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:57:05Z","timestamp":1794887825008,"version":"4.9.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universita degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jneuroim.2025.578734","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T14:19:36Z","timestamp":1756045176000},"page":"578734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review"],"prefix":"10.1016","volume":"408","author":[{"given":"Sara","family":"Cornacchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano Ugo","family":"Verza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Schiavolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Spagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebe","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Leccese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Barilaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Massacesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578734_bb0005","article-title":"Occult bowel cancer presenting as Morvan syndrome","volume":"16","author":"Alagoda","year":"2023","journal-title":"BMJ Case Rep. CP"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2015.08.035","article-title":"Clinical validity of PROMIS\u00ae pain interference and pain behavior in diverse clinical populations","volume":"73","author":"Askew","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200041","article-title":"Early-stage Contactin-associated protein-like 2 limbic encephalitis","volume":"10","author":"Benoit","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"PAIN"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/ana.27177","article-title":"Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease","author":"Ceronie","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0035","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mus.26868","article-title":"AANEM - IFCN glossary of terms in neuromuscular Electrodiagnostic medicine and ultrasound","volume":"62","author":"Dengler","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0045","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ejp.1572","article-title":"Heterogeneous presentation of caspr2 antibody-associated peripheral neuropathy \u2013 a case series","volume":"24","author":"Ellwardt","year":"2020","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG\u2013positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0055","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3892\/ol.2016.4922","article-title":"Paraneoplastic Morvan\u2019s syndrome following surgical treatment of recurrent thymoma: a case report","volume":"12","author":"Gali\u00e9","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/ene.13922","article-title":"Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study","volume":"26","author":"Gastaldi","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0065","doi-asserted-by":"crossref","unstructured":"Giacomo, R.D., Sebastiano, D.R., Cazzato, D., Andreetta, F., Pozzi, P., Cenciarelli, S., Deleo, F., Pastori, C., Didato, G., Curtis, M. de, Villani, F., 2020. Expanding clinical spectrum of Caspr2 antibody-associated disease: warning on brainstem involvement and respiratory failure. J. Neurol. Sci. 413. doi:https:\/\/doi.org\/10.1016\/j.jns.2020.116865.","DOI":"10.1016\/j.jns.2020.116865"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0070","article-title":"Delayed onset of severe chronic pain in CASPR2 autoantibody\u2013associated Morvan syndrome in a former UK swine abattoir worker","volume":"3","author":"Goebel","year":"2025","journal-title":"Pain Rep."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0075","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00415-024-12224-4","article-title":"Different pain phenotypes are associated with anti-Caspr2 autoantibodies","volume":"271","author":"Greguletz","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1097-4598(200102)24:2<151::AID-MUS10>3.0.CO;2-7","article-title":"When is myokymia neuromyotonia?","volume":"24","author":"Gutmann","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0085","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0090","doi-asserted-by":"crossref","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, MF., Kind, P., Parkin, D., Bonsel, G., Badia, X., 2011. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727\u20131736. doi:https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","DOI":"10.1007\/s11136-011-9903-x"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1106214","article-title":"Clinical spectrum of contactin-associated protein 2 autoimmune encephalitis in children","volume":"17","author":"Hu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ncl.2021.06.009","article-title":"Electrodiagnostic assessment of Hyperexcitable nerve disorders","volume":"39","author":"Hutto","year":"2021","journal-title":"Neurol. Clin. Electromyogr."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.815976","article-title":"Phenotypic spectrum of CASPR2 and LGI1 antibodies associated neurological disorders in children","volume":"10","author":"Jiang","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti\u2013Contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0120","series-title":"Handbook of Clinical Neurology, Clinical Neurophysiology: Diseases and Disorders","first-page":"281","article-title":"Chapter 17 - peripheral nerve hyperexcitability","author":"Katirji","year":"2019"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3988\/jcn.2020.16.4.699","article-title":"Anti-CASPR2-antibody-positive Isaacs\u2019 syndrome presenting with Myokymia, neuropathic pain, and hyperhidrosis","volume":"16","author":"Kim","year":"2020","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0135","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.25371","article-title":"Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy","volume":"55","author":"Lahoria","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0145","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/WNL.0000000000002037","article-title":"Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome","volume":"85","author":"Laurencin","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","article-title":"Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study","volume":"15","author":"Lauria","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-022-02584-7","article-title":"Isaacs\u2019 syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jocn.2022.05.007","article-title":"Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort","volume":"101","author":"Li","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577569","article-title":"Tacrolimus as a therapeutic option in patients with acquired neuromyotonia","volume":"355","author":"Liu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.25310","article-title":"LGI1 and CASPR2 neurological autoimmunity in children","volume":"84","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2011.08.024","article-title":"Morvan\u2019s syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex","volume":"312","author":"Loukaides","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/aian.aian_904_23","article-title":"Autoimmune pain due to CASPR2 responsive to tocilizumab","volume":"27","author":"Maramattom","year":"2024","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0185","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000404","article-title":"Improving the antibody-based evaluation of autoimmune encephalitis","volume":"4","author":"McCracken","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0190","first-page":"163","article-title":"Conducting systematic reviews of association (etiology): the Joanna Briggs institute\u2019s approach","volume":"13","author":"Moola","year":"2020","journal-title":"JBI Evid. Implement."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0195","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nmd.2022.06.001","article-title":"Refractory Morvan syndrome responsive to rituximab: a case report and review of the literature","volume":"32","author":"Nawfal","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0200","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/ene.12164","article-title":"Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies","volume":"20","author":"Ong","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.20517\/2347-8659.2017.67","article-title":"Steroids and plasma exchange in Isaacs\u2019 syndrome with anti-Caspr2 antibodies","volume":"5","author":"Orsucci","year":"2018","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00265","article-title":"Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis","volume":"9","author":"Pinatel","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5152\/npa.2016.14816","article-title":"Clinical, electrophysiological, and serological evaluation of patients with cramp-fasciculation syndrome","volume":"54","author":"Poyraz","year":"2017","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical character of CASPR2 autoimmune encephalitis: a multiple center retrospective study","volume":"12","author":"Qin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ana.26189","article-title":"Leucine-rich glioma-inactivated 1 versus Contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons","volume":"90","author":"Ramanathan","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0235","doi-asserted-by":"crossref","first-page":"768","DOI":"10.25259\/JNRP-2022-3-49","article-title":"Morvan\u2019s syndrome: an unusual presentation of a solid pseudopapillary pancreatic tumor","volume":"13","author":"Saluja","year":"2022","journal-title":"J Neurosci Rural Pract"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577491","article-title":"Case report: isolated muscle neuromyotonia, as presenting feature of Isaacs\u2019 syndrome","volume":"353","author":"Samogalskyi","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/aian.AIAN_574_20","article-title":"Clinical profile and treatment response in patients with CASPR2 antibody-associated neurological disease","volume":"24","author":"Shivaram","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0250","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s10072-018-3515-y","article-title":"Morvan\u2019s syndrome\u2014is a pathogen behind the curtain?","volume":"39","author":"Singh","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jocn.2017.02.063","article-title":"Isaacs syndrome with CASPR2 antibody: a series of three cases","volume":"41","author":"Song","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0260","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.nmd.2023.06.010","article-title":"Clinical, neurophysiological and serological clues for the diagnosis of neuromyotonia and distinction from cramp-fasciculation syndrome","volume":"33","author":"Spagni","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200313","article-title":"Serological markers of clinical improvement in MuSK myasthenia gravis","volume":"11","author":"Spagni","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","article-title":"Clinical manifestations of patients with CASPR2 antibodies","volume":"281","author":"Sunwoo","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0275","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/dmcn.14179","article-title":"Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies","volume":"61","author":"Surana","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0280","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related Morvan syndrome","volume":"11","author":"Swayang","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0285","doi-asserted-by":"crossref","first-page":"e2290","DOI":"10.1212\/WNL.0000000000009523","article-title":"CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension","volume":"94","author":"Syrbe","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0290","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1007\/s00415-022-11248-y","article-title":"Guillain\u2013Barr\u00e9-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity","volume":"269","author":"Tan","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0295","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(16)31459-3","article-title":"Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies","volume":"389","author":"Vale","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0300","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody\u2013associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0305","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","article-title":"Association of leucine-rich glioma inactivated protein 1, contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia","volume":"75","author":"Vincent","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2025.578734_bb0310","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mus.27188","article-title":"Peripheral nerve hyperexcitability syndrome: a clinical, electrophysiological, and immunological study","volume":"63","author":"Wu","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578734_bb0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12883-016-0555-x","article-title":"A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:34:32Z","timestamp":1782261272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"alternative-id":["S0165572825002152"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578734","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578734"}}